Pursuit of the Optimal Antithrombotic Regimen for Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Who Undergo Subsequent Percutaneous Coronary Intervention

Am J Cardiol. 2019 May 15;123(10):1736. doi: 10.1016/j.amjcard.2019.02.036. Epub 2019 Mar 4.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acute Coronary Syndrome*
  • Anticoagulants
  • Fibrinolytic Agents
  • Hirudins
  • Humans
  • Percutaneous Coronary Intervention*

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Hirudins